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Focal glomerular sclerosis
EDITORIAL
In 1957 Rich [1] presented observations in 20 child-
ren with the nephrotic syndrome who died between
several months and five years after the onset of edema.
One-half of these children died from infection. He
described a progressive sclerosis of glomeruli starting
in the juxtamedullary region of the kidney and sugges-
ted that this was the usual way in which lipoid neph-
rosis progressed. A few years later, studies of renal
biopsy specimens from patients with the idiopathic
nephrotic syndrome revealed a particular group that
was characterized by the presence of focal scierosing
glomerular lesions as distinct from others with mini-
mal or diffuse glomerular lesions [2—4]. It is only in
recent years that a clear correlation has been estab-
lished between these focal lesions and a specific
clinical course. A high incidence of microscopic
hematuria, corticosteroid resistance and developing
renal insufficiency in nephrotic patients with this
finding has now been reported by most authors [5—17].
Since the lesions under discussion are characterized
by focal involvement of glomeruli and by the sclerotic
changes which take place in affected glomeruli, the
terms focal glomerular sclerosis (FGS) or focal scler-
osing glomerulonephropathy [17] seem appropriate.
Other names such as focal sclerosing glomeruloneph-
ntis [4, 16] or focal glomerulosclerosis [11, 15, 20]
have been proposed. In our opinion the word 'glomer-
ulonephritis' should be avoided because of the con-
fusion it may introduce in reference to focal and
segmental glomerulonephritis [9]. The term 'focal gb-
merulosclerosis' is also confusing since, for decades,
the word 'glomerulosclerosis' has been used for the
small sclerotic glomeruli often found in infant
kidneys [18, 19].
The frequent histologic finding of FGS in nephrotic
patients whose clinical presentation at onset could not
be distinguished from that of 'nephrosis,' or who
might have exhibited minimal glomerular lesions on a
previous biopsy specimen [3, 5, 8, 13, 14, 16, 17],
raises an important question as to the relationship
between 'minimal lesion nephrotic syndrome' (M LNS)
and this 'disease' (FGS). A recent report of the
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possible recurrence of the nephrotic syndrome and
the focal lesion in transplanted kidneys suggests that
a humoral factor may be operative which antedates
the glomerular structural changes. Accurate diagnosis
of FGS in nephrotic patients may therefore be of con-
siderable practical importance.
Pathology. Two main histological patterns of in-
volvement may be seen in the affected glomeruli. The
clinicopathologic correlations we have been able to
establish for these two variants of FGS seem to indi-
cate that, from a practical point of view, they should be
distinguished one from another [14].
In one, the focal changes are segmental, i.e, they
are limited to only part of the involved tuft, the other
capillary loops showing no modification. For this
form we have proposed the term 'focal and segmental
hyalinosis and/or sclerosis' (FSH). In the other form,
the whole of the involved tufts is completely scierosed.
The terms focal and global fibrosis or 'focal glomerular
obsolescence' (FGO) seem appropriate [14]. In some
instances, all grades of involvement may be seen in the
affected gbomeruli (from discrete segmental hyalinosis
or sclerosis to complete glomerular obsolescence) of
the same specimen, thus confirming that there is no
fundamental difference between these two histo-
logical patterns. However, in most patients, the glom-
erular lesions are homogeneous in an individual
case.
A mild diffuse mesangial hypercellularity may be
seen in both forms. It may be found in association with
the focal lesion in the affected glomeruli as well as in
the remaining ones [16, 17].
1) Focal and segmental hyalinosis and/or sclerosis
(FSH). As pointed out by Rich [1] the lesion seems to
predominate in the deeper cortex and it is the juxta-
medullary gbomeruli that are mainly affected. The
most characteristic feature of the lesion at an early
stage is localized hyaline deposition and an absence of
hypercellularity in the affected segment (Fig. 1).
Subendothelial fibrinoid deposits as well as foamy
endocapillary cells may be present in the middle of the
hyalinized area. This abnormal substance is eosino-
philic, refractile, strongly periodic acid-Schiff-positive,
stains either green or red with trichrome light-green,
—
 
_
_
_
 
N
IL
! t 
356 Habib
Fig. 1. Focal and segmental hyalinosis (x 600).
and silver-negative. Later, the segmental lesion is
characterized by an increase in mesangial fibrillar
material which is periodic acid-Schiff-positive and
silver-positive. Both hyaline deposition and sclerosis
are most often present. The result of these various
changes is obliteration of the capillary lumens. The
involved capillary loops stick together irregularly with
direct adhesion of part of the tuft to the adjacent Bow-
man's capsule. Epithelial crescents are almost always
absent. The rest of the tuft and the other glomeruli
show only 'minimal changes.' However, as already
mentioned, moderate diffuse mesangial hypercellu-
larity may be present.
Vascular changes are rare, but in some instances
subendothelial hyalinosis of afferent arterioles may be
observed [16, 17]. Tubular atrophy and interstitial
fibrosis are always present. Their involvement seems
proportional to the glomerular damage. Therefore,
the undetected presence of focal glomerular lesions
should be suspected when focal tubular and inter-
stitial changes are found associated with a so-called
'minimal lesion nephrotic syndrome.' Foam cells may
be seen in the interstitium.
Electron microscopy confirms these findings, al-
though descriptions differ. In the affected loops some
observers [15, 21] insist on an increase in mesangial
matrix and the deposition of collagen. For Rumpelt
and Thoenes [22] the characteristic feature is the sub-
endothelial apposition of a fine 'filamentous mesangial
matrix-like' material. For Hinglais [23] and Hyman
and Burkholder [17], it is the presence of abnormal
electron-dense deposits which infiltrate the basement
membrane with or without obstruction of the capillary
lumens. Various combinations of paramesangial,
subendothelial and intramembranous electron-dense
deposits have been reported [17]. In direct contact with
this abnormal basement membrane, Hinglais [23] des-
cribes a loose, slightly argyrophilic basement mem-
brane-like material which pushes away the epithelial
cells and infiltrates between them. The adhesion of the
affected part of the tuft to Bowman's capsule is made
possible by the presence of this cloudy and often
cellular material. Fatty vacuoles may be seen either in
the middle of the abnormal deposit or within the
cytoplasm of endothelial cells [17]. Apart from these
segmental lesions, Hinglais [23] finds no conspicuous
changes in the glomeruli while others [17, 20, 22]
describe either slight to moderate irregular thickening
and even splitting [15] of the capillary basement mem-
branes, or an increase in mesangial matrix material
[17]. Fusion of epithelial cell foot processes has been
confirmed by all authors [15, 17, 20—23].
Fluorescent microscopy [17, 24, 25] shows no bind-
ing of anti-IgM serum, a weaker fixation of anti-IgG
and of anti-C3 and C4 and often (but not always) a
binding of anti-beta-lipoprotein serum on the segmen-
tal lesions of the affected glomeruli. The presence of
fibrin/fibrinogen has been reported in 10 of the 31
cases studied by Hyman and Burkholder [17], but to a
much less extent than that of the immunoglobulins or
C3. These authors found that the in vitro immuno-
histologic guinea pig complement fixation test was
positive in those areas where IgO and/or 1gM were
observed.
FSH may be found very early in the course of the
disease. We have seen such lesions as soon as one
month after onset [14, 16], and this has been con-
firmed by the results of the International Collabora-
tive Study [10]. However, it is sometimes found later
in patients whose previous biopsy specimen had
shown optically normal glomeruli. Examinations of
serial biopsy specimens has revealed two other im-
portant facts: first, FSH may be seen in patients whose
first biopsy specimen was diagnosed as diffuse mes-
angial proliferative glomerulonephritis. The possibility
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of transformation must be kept in mind when diffuse
mesangial proliferative glomerulonephritis is found in
a biopsy specimen from a patient presenting with the
nephrotic syndrome, especially if it does not respond
to steroids. Second, an extension of the segmental
lesions may occur in corticosteroid-resistant patients,
both in terms of an increasing number of affected
glomeruli and more involvement of the capillary
loops within each glomerulus, often with multiple
foci within the same tuft. The end-stage of the lesion is,
as may be expected, complete sclerosis of the tuft.
This progression to chronic end-stage glomeruloneph-
ntis has been well domonstrated in serial examina-
tion of renal material by Hyman and Burkholder
[17].
FSH is not a specific histopathologic lesion since
similar if not identical lesions may be seen in various
circumstances such as persistent idiopathic proteinuria,
Alport's syndrome, hypertension, pyelonephritis, etc.
However, when this pattern is found in association
with the nephrotic syndrome, or in the presence of a
persistent and idiopathic proteinuria [16, 26] it should
be considered as an important finding even if only a
few glomeruli and capillary loops are affected. It must
be emphasized that unlike other types of focal lesions
the eventual prognosis is not dependent on the number
of glomeruli initially affected.
FSH in its early stages is easy to differentiate from
the other type of focal and segmental lesion, i.e., focal
and segmental glomerulonep hr it is (GN), primarily
because of the deposition of hyaline and the absence
of hypercellularity in the affected segments. However
once the sclerotic changes take place the differentiation
may be difficult. In focal and segmental GN, as en-
countered in the Schönlein-Henoch syndrome or
recurrent idiopathic macroscopic hematuria [9, 27,
28], the segmental lesion is characterized in its early
stage by proliferation of both endo and extracapillary
cells. Sometimes fibrinoid material may be seen among
the proliferated cells. Later, collagen fibers are more
conspicuous than proliferated cells and a portion of the
glomerular tuft is replaced by a fibrous triangle which
is adherent to Bowman's capsule. This type of lesion is
rarely associated with the nephrotic syndrome. Fluor-
escent microscopy may help in differentiating FSH
from focal and segmental GN. In most of the latter
cases, deposits of IgA as well as IgG and C3 are found
in the mesangial stalks of all glomeruli.
2) Focal glomerular obsolescence (FGO.). The co-
existence of optically normal glomeruli and sclerosed
glomeruli is characteristic of this type of lesion. The
affected glomeruli are shrunk into small wafer-like
formations of low cellularity that are positive for col-
lagen stains, and irregularly disseminated over the
renal parenchyma. Only those cases should be con-
sidered as significant in which at least 15 to 20% of
glomeruli are sclerosed, and in which the sclerosis is
associated with conspicuous interstitial and tubular
damage.
The great difficulty in children is to differentiate
such atrophic glomeruli from 'congenital glomerulo-
sclerosis,' a developmental anomaly which is frequently
found in the kidneys of infants and young children.
In congenital glomerulosclerosis, as described by
several authors [18, 19], there is neither accompanying
tubular atrophy nor interstitial fibrosis.
Several glomerular diseases, such as endo and extra-
capillary glomerulonephritis or thrombotic micro-
angiopathy may lead to focal glomerular obsolescence
but when this histological picture is associated with a
nephrotic syndrome, it should again be considered as
an important finding.
Clinical course. Although the finding of FGS in
nephrotic patients has been mentioned in several
recent reports, few extensive studies have been devoted
to this clinicopathologic entity. We reported 49
patients in 1971 [14] who represented l2% of our total
number of nephrotic patients, and then 88 patients
in an International Symposium on Glomeruloneph-
ntis held in Melbourne in 1972 [16]. All were children.
Our findings have been confirmed in smaller series
by several authors [10, 11, 15, 17].
In our series boys were more often affected than
girls (52 boys and 36 girls). This has not been the
experience of Glasgow and White, 13 of the 17 cases
reported by them being girls [15]. In a recent paper
Hyman and Burkholder gave a figure of 4:3 for the
male to female ratio [17].
FGS may be found in patients presenting with a ne-
phrotic syndrome at any age, including the first year of
life. In Hyman and Burkholder's report [17], the mean
age at onset was 25.5 years (range: 3 to 61 years). In
two children in our series, the nephrotic syndrome was
present at the time of birth. Glasgow and White [15]
mention a case occurring at two months of age. How-
ever, none of the six cases of our series whose neph-
rotic syndrome had been discovered in the first year of
life had a renal biopsy earlier than two years after the
onset of the disease. Six of our patients had an affected
sibling and in three of these familial cases the neph-
rotic syndrome had occurred in the first year of life. The
high incidence of FGS in familial and/or infantile
nephrotic syndrome is worth emphasizing, and it may
account for the unfavorable prognosis associated with
these forms of the nephrotic syndrome [29].
No preceding acute illness is usually apparent, but as
in MLNS the first symptoms of renal disease sometimes
follow an upper respiratory tract infection.
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The nephrotic syndrome, which is the presenting
symptom in most cases, is usually severe with extensive
edema and poorly selective proteinuria. Only two of
the 16 patients of Glasgow and White had highly
selective proteinuria [15]. Nephrotic syndrome is
accompanied by hematuria in two-thirds of the cases,
but it has rarely been macroscopic in our experience.
Hypertension and azotemia are present at the onset
in only 10% of children, but it seems to be more fre-
quent in adults [17].
Intercurrent complications, mainly infectious and
thrombotic in nature, occurred in one-fourth of the
children in our series. They were the cause of death in
six patients, all within the first two years of the
disease.
Most patients with FGS do not respond to corti-
costeroids. In the series of Glasgow and White [15],
one of 15 patients treated with steroids responded,
while in the report of the International Study [10] two
of 12 patients were steroid-sensitive. However, in 25%
of our patients proteinuria decreased or disappeared
completely after the administration of prednisone.
Three of these 'responders' became steroid-resistant
after a few months of treatment. Some benefit was
obtained with chlorambucil in steroid-resistant pa-
tients; in two of 38 such patients a complete remission
occurred while proteinuria decreased in five. In Glas-
gow and White's series, 11 patients were treated with
cyclophosphamide and four with azathioprine, but
none responded. In serial renal biopsy specimens
Hyman and Burkholder have found histologic pro-
gression of the glomerular lesions despite immuno-
suppressive therapy [17].
The prognosis of the disease is poor but in our ex-
perience this is true for the steroid-resistant patients
only (Table 1). With an average follow-up of seven
years (range: 3 months to 22 years), 25 patients (28%)
have died or are on hemodialysis; one has chronic
-
Fig. 2. Focal glotnerular sclerosis: Actuarial survival curve. The
5O% statistical mortality is around the 16th year but patients
with FGO (focal glomerular obsolescence) tend to deteriorate
less quickly than those with FSH (focal and segmental hyalinosis
and/or sclerosis).
renal failure, five have hypertension with normal
renal function and 24 have a persistent nephrotic syn-
drome. Three patients have been transplanted; the
nephrotic syndrome recurred soon after transplanta-
tion in two of these patients. The 50% statistical
mortality is around the 16th year but in some of our
patients chronic renal failure developed as early as the
second year of the disease (Fig. 2). In Hyman and
Burkholder's report [17] the appearance of end-stage
renal disease occurred 6 to 7 years after the onset of
disease, although renal death was observed as early as
two and as late as 11 years after onset. The 50%
statistical appearances of hypertension and renal
insufficiency after the apparent onset of disease were
5.5 and 6.5 years, respectively.
Table 1. Focal glomerular sclerosis: Correlations between initial response to therapy (corticosteroids and/or immunosuppressive drugs)
and clinical course
Status at last Cases
examination N
Accidental
death
Renal death Chronic
renal failure
Hypertension Nephrotic
syndrome
Asymptomatic
proteinuria
Complete
remission
Average
follow-up.
years
Nonresponders (64 cases)
FSH 52 6 14 1 2 16 3 10 3.66
FGOb 12 0 5 0 1 4 2 0 9.41
Responders (24 cases)
FSH 12 0 0 0 2 2 5 3 11.25
FGO 12 0 0 0 0 2 2 8 8.75
Total 88 6 19 1 5 24 12 21 7.25
FSH: focal and segmental hyalinosis and/or sclerosis.
b FGO: focal glomerular obsolescence.
FSH 64 36 43
FGO 24 24 23
too . -
Number of living patients at beginning of each interval
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In fact, when the two histopathological variants of
FGS (i.e., focal and segmental hyalinosis [FSH] and
focal glomerular obsolescence [FGO]) are analysed
separately, a few differences appear between their
clinical course which suggest that complete focal
sclerosis of the glomerulus is less severe than pro-
gressive hyalinosis or sclerosis.
In our experience: hematuria is less frequent in
FGO (45%) than in FSH (78%) (P<O.01). Only
patients with FSH have transient azotemia and/or
hypertension at the onset. Patients with FSH are much
less likely to respond to steroids (80%) while only
39% with FGO are nonresponders (P<0.001). This
tendency is also present with immunosuppressive drugs
though this is not statistically significant (59% with
FSH as against 36% with FGO). A clinical course
characterized by a relapsing nephrotic syndrome
which responds to corticosteroids is rare (18.5%) with
FSH though present in one-half the patients with FGO
(P=0.0l). The rate of progression is similar in both
groups, but patients with FGO tend to deteriorate less
quickly than those with FSH; among the patients fol-
lowed more than five years, 15 of the 41 with FSH had
already died whereas all 19 patients with FGO were
alive (Fig. 2).
Conclusion. In spite of numerous studies the signifi-
cance of the lesions of FGS in nephrotic patients is
still poorly understood.
The first question raised is a practical one: what is
the clinical significance of the finding of FGS in a
nephrotic patient?
The clinical course of the disease can be deduced
from the few reports already mentioned and answers
this question. The discovery of FGS, even when the
lesions do not appear extensive, implies an unfavorable
prognosis in one-half of the patients, namely, those in
whom hematuria and the nephrotic syndrome are
persistent and who never respond either to steroids or
to immunosuppressive drugs. Furthermore, the assoc-
iation of FGS and steroid-resistant nephrotic syn-
drome is sufficiently frequent to create doubts about
the correctness of a diagnosis of MLNS even when
renal tissue reveals normal glomeruli. It must be kept
in mind that the focal character of the lesions and their
predominance at the corticomedullary junction make
their detection difficult in a superficial biopsy or in a
biopsy specimen which contains few glomeruli. How-
ever the prognosis of FGS is not always bad and, in our
experience, a fatal outcome has not been observed in
cases who either improved slowly during or after
withdrawal of treatment, or who had complete and
even incomplete responses to therapy [16].
The second question is theoretical: why and how do
these focal lesions occur?
The question arises as to whether the lesions could
be secondary to corticosteroid therapy since there is a
similarity between FSH and lesions experimentally
induced in the kidney by cortisone [30, 31]. This hy-
pothesis does not seem very realistic for two reasons:
first, focal glomerular lesions do not occur in all
patients who receive prolonged corticosteroid therapy
whether they have a nephrotic syndrome or a non-
renal disease. Secondly, such lesions can be seen in the
absence of any corticosteroid therapy [1, 5, 12, 13, 30].
Some authors [1, 3—5, 8, 32, 33] believe that FGS
represents a 'complication' of minimal lesion neph-
rotic syndrome (MLNS). The focal lesions would then
be viewed as only a stage in the development towards
the more or less complete glomerular sclerosis which is
found on autopsy examination of patients with
nephrosis who die of renal failure. This concept is
supported by the observation that in many instances
focal glomerular lesions are found in patients who have
had a previous biopsy which showed only minimal
glomerular lesions. Unfortunately, the focal character
of the glomerular lesion makes this difficult to assess,
especially as some specimens contain few glomeruli.
By electron microscopy Duffy et al [34] have found
fibrin, platelet aggregates and subendothelial de-
posits in 'active cases of lipoid nephrosis.' These
authors suggested that these findings were compatible
with the concept that the formation of small fibrin
aggregates adherent to glomerular capillary walls
could lead to focal capillary collapse and eventual
obliteration of the capillary lumen in those areas.
Negative immunofluorescence in the normal glomeruli
is another argument in favor of the close relationship
which exists between minimal and focal glomerular
lesions associated with the nephrotic syndrome.
Moreover, symptomatology, especially at onset, is
very similar to that of MLNS. The main difference
between these two groups of patients is in their res-
ponse to steroids. However this criterion is not reli-
able since patients with FGS may respond to steroids
(18 in our series and 18 in that of Siegel et al [35])
while some patients with MLNS may not [13].
For others [21], FGS is a distinct disease, since in
most patients certain clinical findings are altogether
different from those in MLNS. Poorly selective
proteinuria, persistent hematuria, resistance to ster-
oids, lack of remissions, progression to chronic renal
failure, all in a patient with a persistent and severe
nephrotic syndrome, are likely to indicate the presence
of FGS. The discovery of FGS in early biopsy
specimens (29 in our series, 9 in that of Berger et al
[5], 12 in that of Churg et al [10]), is further evidence
that this condition could represent a separate form of
nephrosis. This hypothesis would be satisfactory if
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such findings were present in all cases of the nephrotic
syndrome which present with FGS. Unfortunately,
this is not so, and it is therefore difficult to derive a
firm conclusion,
Clinicopathologic observations indicate that there
are two populations of such patients. In most in-
stances, the lesions of FGS seem to be present from
the onset, and they are then associated with a severe
corticosteroid-resistant disease. Nevertheless, in other
cases, they seem to develop in a previously normal
kidney and the clinical course is that of a relapsing
nephrotic syndrome which is more or less corticos-
teroid-sensitive.
The finding of immunoglobulins and C3, as well as
electron-dense deposits in various glomerular diseases,
has been accepted as evidence that immune mech-
anisms may be operative in their pathogenesis. How-
ever in FGS, as pointed out by Hyman and Burk-
holder [17], these deposits might represent a renal
glomerular response to other toxic or metabolic
pathophysiologic factors that have not yet been de-
fined. In this case, localization of plasma proteins or
immunologic reactants could result from physical
entrapment in locally injured capillary walls.
The possibility of recurrence of a nephrotic syn-
drome, with or without recurrence of the lesions of
FGS, in transplanted patients as found by Hoyer et al
[20] and in two of our own patients, suggests that the
pathogenesis of the steroid-resistant idiopathic neph-
rotic syndrome may involve systemic circulating fac-
tors.
FOS, when associated with a nephrotic syndrome,
emerges as a histopathologic entity. It usually indicates
a progressive course, especially in steroid-resistant
patients. No specific treatment seems effective, al-
though remission sometimes seems to be obtained with
immunosuppressive drugs. Renal transplantation may
be of questionable value since the disease tends to
recur.
Renée Habib
Paris
Reprint requests to Dr. Renée Habib, Unite de Recherches sur
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